Prellis Biologics
Developer of a bioprinting technology designed to recreate and engineer human tissues in vitro. The company's technology precisely reproduces the human immune response through the creation of lymph no...
Valuation
$0
Share Price
N/A
Total Raised
$70.2M
Last Round
N/A